The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
COVID-19 spawns vaccine wars | Medical Xpress | When Australia, India, Japan and the US--countries strategically allied under the so-called Quad (Quadrilateral Security Dialog)--switched focus to fighting COVID-19, it was seen as one more of the several 'proxy wars' spawned by the pandemic. The 'Quad Vaccine,' announced at a virtual summit of the leaders of the four countries on 12 March, is based on a vaccine developed by the US transnational, Johnson & Johnson, produced by India's Biological E Limited, and funded by the other two partners. The plan is to churn out a billion doses by the end of 2022. Vishnu Prakash, commentator on security issues and former member of India's diplomatic corps, tells SciDev.Net that the Quad has a "focused agenda of raising the cost of misadventure in the region by any expansionist power". While Prakash and other commentators carefully refrain from naming any country as the focus of Quad, there is little doubt that the expansionist power in question is China. Says Pankaj Mohan, a leading academic who specializes in Chinese and East Asian studies: "Chinese media have been vocal against the 'Asian NATO' and, notably, the Global Times on 13 March talked about COVID-19 vaccines being used to weaken China's influence in the whole region." Srikanth Kondapalli, professor in Chinese studies at the Jawaharlal Nehru University, New Delhi, says that while China is acknowledged as 'factory to the world', India has long had an advantage when it came to the manufacture of drugs and vaccines so that it has a reputation for being 'the world's pharmacy'.
When Australia, India, Japan and the US--countries strategically allied under the so-called Quad (Quadrilateral Security Dialog)--switched focus to fighting COVID-19, it was seen as one more of the several 'proxy wars' spawned by the pandemic.
The 'Quad Vaccine,' announced at a virtual summit of the leaders of the four countries on 12 March, is based on a vaccine developed by the US transnational, Johnson & Johnson, produced by India's Biological E Limited, and funded by the other two partners. The plan is to churn out a billion doses by the end of 2022.
Vishnu Prakash, commentator on security issues and former member of India's diplomatic corps, tells SciDev.Net that the Quad has a "focused agenda of raising the cost of misadventure in the region by any expansionist power".
While Prakash and other commentators carefully refrain from naming any country as the focus of Quad, there is little doubt that the expansionist power in question is China.
Says Pankaj Mohan, a leading academic who specializes in Chinese and East Asian studies: "Chinese media have been vocal against the 'Asian NATO' and, notably, the Global Times on 13 March talked about COVID-19 vaccines being used to weaken China's influence in the whole region."
Srikanth Kondapalli, professor in Chinese studies at the Jawaharlal Nehru University, New Delhi, says that while China is acknowledged as 'factory to the world', India has long had an advantage when it came to the manufacture of drugs and vaccines so that it has a reputation for being 'the world's pharmacy'.
From the diaries ...
J&J Vaccine: Developed at Janssen in Leiden
JUST IN: #JNJ has announced that vaccinations with its #COVID19 single-shot vaccine will resume for all adults aged 18 years and older in the U.S., under Emergency Use Authorization, following a decision from @CDCgov and the @US_FDA. Learn more: [_link] pic.twitter.com/EsDoBvLCpS— Johnson & Johnson (@JNJNews) April 24, 2021
JUST IN: #JNJ has announced that vaccinations with its #COVID19 single-shot vaccine will resume for all adults aged 18 years and older in the U.S., under Emergency Use Authorization, following a decision from @CDCgov and the @US_FDA. Learn more: [_link] pic.twitter.com/EsDoBvLCpS
China, India aim for peace but keep edging toward conflict at border [_link]— Newsweek (@Newsweek) September 8, 2020
China, India aim for peace but keep edging toward conflict at border [_link]
Indian police clamp curbs on media coverage of gun battles in occupied Kashmir | Dawn News |
After receiving a supply of Indian vaccines and delivering princess Latifa to the Sheikh of Dubai ...
Pakistani, Indian officials held talks in Dubai over Kashmir 'Sapere aude'
by Frank Schnittger - Dec 11 1 comment
by Frank Schnittger - Dec 2 2 comments
by Oui - Dec 10
by Oui - Dec 9 6 comments
by Frank Schnittger - Dec 3 2 comments
by gmoke - Nov 28
by Frank Schnittger - Nov 21 10 comments
by Oui - Dec 12
by Frank Schnittger - Dec 111 comment
by Oui - Dec 1112 comments
by Oui - Dec 96 comments
by Oui - Dec 88 comments
by Oui - Dec 718 comments
by Oui - Dec 54 comments
by Frank Schnittger - Dec 32 comments
by Oui - Dec 214 comments
by Frank Schnittger - Dec 22 comments
by Oui - Dec 26 comments
by Oui - Dec 114 comments
by Oui - Dec 14 comments
by Oui - Nov 306 comments
by Oui - Nov 289 comments
by Oui - Nov 276 comments
by gmoke - Nov 26
by Oui - Nov 268 comments